US Rights Deal Will Make Proleukin Clinigen's Biggest Product

 
• By Sten Stovall

Clinigen's planned purchase of US rights to Proleukin will give it global ownership of the IL-2 drug.

Handshake
Clinigen Agrees To Acquire US Rights To Novartis' cancer drug Proleukin • Source: Shutterstock

More from Strategy

More from Business